Snark BidCo (SE) has acquired a 78.2% stake in Sleep Cycle (SE), marking the latest move to consolidate control over the healthcare sector firm through an acquisition valued at $128 million.

AquirerAcquirer TypeTargetSectorDeal Value (USD)
Snark BidCo (SE)-Sleep Cycle (SE)Healthcare128,000,000
Type of TransactionClose DateAnnouncement DateStake Acquired (%)
Acquisition2026-07-012026-05-1178.2
Buy-side Financial AdvisorsSell-side Financial AdvisorsBuy-side Legal AdvisorsSell-side Legal Advisors
Altea Partners-Setterwalls Advokatbyrå, Vinge-

The deal allows Snark BidCo to integrate Sleep Cycle's operations and achieve a controlling stake, with the possibility of forced redemption for any remaining shares after full completion. The transaction is conditional on accepting more than 90% ownership in Sleep Cycle.

Deal Mechanics

Upon acceptance by shareholders during an extended acceptance period ending July 17th, Snark BidCo will proceed to acquire the remaining shares. This move solidifies its financial standing with a position exceeding 78%. The deal's full closure hinges on regulatory approval and shareholder cooperation.

Strategic Rationale

The acquisition is seen as a strategic consolidation play aimed at strengthening Snark BidCo’s market presence within the healthcare industry. By integrating Sleep Cycle, Snark BidCo hopes to leverage synergies for operational efficiencies and growth opportunities in targeted markets.

Financial Context

Despite the deal's value being publicly disclosed as $128 million, significant financial documentation has been provided to ensure transparency and compliance with Swedish takeover regulations. The transaction’s structure includes provisions that protect minority shareholders while ensuring a smooth transition for majority control.

Advisors

The buy-side was supported by Altea Partners for financial advisory services alongside legal counsel from Setterwalls Advokatbyrå and Vinge. No sell-side advisors were disclosed.

Outlook

Looking ahead, Snark BidCo anticipates further consolidations to drive its healthcare portfolio growth and operational efficiency. The company remains committed to reaching the 90% ownership threshold to fully consolidate Sleep Cycle's operations within its larger strategic framework.